Hepatitis B Vaccines Industry Research Report 2023
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
Highlights
The global Hepatitis B Vaccines market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Hepatitis B Vaccines type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Hepatitis B Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hepatitis B Vaccines segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hepatitis B Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hepatitis B Vaccines market.
Hepatitis B Vaccines segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hepatitis B Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hepatitis B Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hepatitis B Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hepatitis B Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Hepatitis B Vaccines market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.
The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- NCPC
- Merck
- Bio Kangtai
- Dynavax
- Hissen
- KM Biologics
- LG Life Sciences
- Serum Institute
Global markets are presented by Hepatitis B Vaccines type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Hepatitis B Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Hepatitis B Vaccines segment by Type
- Yeast Derived
- CHO Derived
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Hepatitis B Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Hepatitis B Vaccines market.
Hepatitis B Vaccines segment by Application
- Children
- Adult
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hepatitis B Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hepatitis B Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hepatitis B Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hepatitis B Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hepatitis B Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Hepatitis B Vaccines Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Hepatitis B Vaccines Revenue of Manufacturers (2018-2023)
Table 9. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Hepatitis B Vaccines Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Hepatitis B Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. GSK Company Information
Table 17. GSK Business Overview
Table 18. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. GSK Hepatitis B Vaccines Product Portfolio
Table 20. GSK Recent Developments
Table 21. NCPC Company Information
Table 22. NCPC Business Overview
Table 23. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. NCPC Hepatitis B Vaccines Product Portfolio
Table 25. NCPC Recent Developments
Table 26. Merck Company Information
Table 27. Merck Business Overview
Table 28. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Merck Hepatitis B Vaccines Product Portfolio
Table 30. Merck Recent Developments
Table 31. Bio Kangtai Company Information
Table 32. Bio Kangtai Business Overview
Table 33. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Bio Kangtai Hepatitis B Vaccines Product Portfolio
Table 35. Bio Kangtai Recent Developments
Table 36. Dynavax Company Information
Table 37. Dynavax Business Overview
Table 38. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Dynavax Hepatitis B Vaccines Product Portfolio
Table 40. Dynavax Recent Developments
Table 41. Hissen Company Information
Table 42. Hissen Business Overview
Table 43. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. Hissen Hepatitis B Vaccines Product Portfolio
Table 45. Hissen Recent Developments
Table 46. KM Biologics Company Information
Table 47. KM Biologics Business Overview
Table 48. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. KM Biologics Hepatitis B Vaccines Product Portfolio
Table 50. KM Biologics Recent Developments
Table 51. LG Life Sciences Company Information
Table 52. LG Life Sciences Business Overview
Table 53. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. LG Life Sciences Hepatitis B Vaccines Product Portfolio
Table 55. LG Life Sciences Recent Developments
Table 56. Serum Institute Company Information
Table 57. Serum Institute Business Overview
Table 58. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 59. Serum Institute Hepatitis B Vaccines Product Portfolio
Table 60. Serum Institute Recent Developments
Table 61. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Hepatitis B Vaccines Sales by Region (2018-2023) & (M Doses)
Table 63. Global Hepatitis B Vaccines Sales Market Share by Region (2018-2023)
Table 64. Global Hepatitis B Vaccines Sales by Region (2024-2029) & (M Doses)
Table 65. Global Hepatitis B Vaccines Sales Market Share by Region (2024-2029)
Table 66. Global Hepatitis B Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Hepatitis B Vaccines Revenue Market Share by Region (2018-2023)
Table 68. Global Hepatitis B Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Hepatitis B Vaccines Revenue Market Share by Region (2024-2029)
Table 70. North America Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 72. North America Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 73. North America Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 77. Europe Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 78. Europe Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 82. Asia Pacific Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 83. Asia Pacific Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 87. Latin America Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 88. Latin America Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 92. Middle East and Africa Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 93. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
Table 96. Global Hepatitis B Vaccines Sales by Type (2024-2029) & (M Doses)
Table 97. Global Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
Table 98. Global Hepatitis B Vaccines Sales Market Share by Type (2024-2029)
Table 99. Global Hepatitis B Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Hepatitis B Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Hepatitis B Vaccines Revenue Market Share by Type (2018-2023)
Table 102. Global Hepatitis B Vaccines Revenue Market Share by Type (2024-2029)
Table 103. Global Hepatitis B Vaccines Price by Type (2018-2023) & (USD/Doses)
Table 104. Global Hepatitis B Vaccines Price by Type (2024-2029) & (USD/Doses)
Table 105. Global Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
Table 106. Global Hepatitis B Vaccines Sales by Application (2024-2029) & (M Doses)
Table 107. Global Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
Table 108. Global Hepatitis B Vaccines Sales Market Share by Application (2024-2029)
Table 109. Global Hepatitis B Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Hepatitis B Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Hepatitis B Vaccines Revenue Market Share by Application (2018-2023)
Table 112. Global Hepatitis B Vaccines Revenue Market Share by Application (2024-2029)
Table 113. Global Hepatitis B Vaccines Price by Application (2018-2023) & (USD/Doses)
Table 114. Global Hepatitis B Vaccines Price by Application (2024-2029) & (USD/Doses)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Hepatitis B Vaccines Distributors List
Table 118. Hepatitis B Vaccines Customers List
Table 119. Hepatitis B Vaccines Industry Trends
Table 120. Hepatitis B Vaccines Industry Drivers
Table 121. Hepatitis B Vaccines Industry Restraints
Table 122. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Hepatitis B Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Hepatitis B Vaccines Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Hepatitis B Vaccines Revenue of Manufacturers (2018-2023)
Table 9. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Hepatitis B Vaccines Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Hepatitis B Vaccines, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. GSK Company Information
Table 17. GSK Business Overview
Table 18. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. GSK Hepatitis B Vaccines Product Portfolio
Table 20. GSK Recent Developments
Table 21. NCPC Company Information
Table 22. NCPC Business Overview
Table 23. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. NCPC Hepatitis B Vaccines Product Portfolio
Table 25. NCPC Recent Developments
Table 26. Merck Company Information
Table 27. Merck Business Overview
Table 28. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Merck Hepatitis B Vaccines Product Portfolio
Table 30. Merck Recent Developments
Table 31. Bio Kangtai Company Information
Table 32. Bio Kangtai Business Overview
Table 33. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Bio Kangtai Hepatitis B Vaccines Product Portfolio
Table 35. Bio Kangtai Recent Developments
Table 36. Dynavax Company Information
Table 37. Dynavax Business Overview
Table 38. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Dynavax Hepatitis B Vaccines Product Portfolio
Table 40. Dynavax Recent Developments
Table 41. Hissen Company Information
Table 42. Hissen Business Overview
Table 43. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. Hissen Hepatitis B Vaccines Product Portfolio
Table 45. Hissen Recent Developments
Table 46. KM Biologics Company Information
Table 47. KM Biologics Business Overview
Table 48. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. KM Biologics Hepatitis B Vaccines Product Portfolio
Table 50. KM Biologics Recent Developments
Table 51. LG Life Sciences Company Information
Table 52. LG Life Sciences Business Overview
Table 53. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. LG Life Sciences Hepatitis B Vaccines Product Portfolio
Table 55. LG Life Sciences Recent Developments
Table 56. Serum Institute Company Information
Table 57. Serum Institute Business Overview
Table 58. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 59. Serum Institute Hepatitis B Vaccines Product Portfolio
Table 60. Serum Institute Recent Developments
Table 61. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Hepatitis B Vaccines Sales by Region (2018-2023) & (M Doses)
Table 63. Global Hepatitis B Vaccines Sales Market Share by Region (2018-2023)
Table 64. Global Hepatitis B Vaccines Sales by Region (2024-2029) & (M Doses)
Table 65. Global Hepatitis B Vaccines Sales Market Share by Region (2024-2029)
Table 66. Global Hepatitis B Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Hepatitis B Vaccines Revenue Market Share by Region (2018-2023)
Table 68. Global Hepatitis B Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Hepatitis B Vaccines Revenue Market Share by Region (2024-2029)
Table 70. North America Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 72. North America Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 73. North America Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 77. Europe Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 78. Europe Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 82. Asia Pacific Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 83. Asia Pacific Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 87. Latin America Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 88. Latin America Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Hepatitis B Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Hepatitis B Vaccines Sales by Country (2018-2023) & (M Doses)
Table 92. Middle East and Africa Hepatitis B Vaccines Sales by Country (2024-2029) & (M Doses)
Table 93. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Hepatitis B Vaccines Sales by Type (2018-2023) & (M Doses)
Table 96. Global Hepatitis B Vaccines Sales by Type (2024-2029) & (M Doses)
Table 97. Global Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
Table 98. Global Hepatitis B Vaccines Sales Market Share by Type (2024-2029)
Table 99. Global Hepatitis B Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Hepatitis B Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Hepatitis B Vaccines Revenue Market Share by Type (2018-2023)
Table 102. Global Hepatitis B Vaccines Revenue Market Share by Type (2024-2029)
Table 103. Global Hepatitis B Vaccines Price by Type (2018-2023) & (USD/Doses)
Table 104. Global Hepatitis B Vaccines Price by Type (2024-2029) & (USD/Doses)
Table 105. Global Hepatitis B Vaccines Sales by Application (2018-2023) & (M Doses)
Table 106. Global Hepatitis B Vaccines Sales by Application (2024-2029) & (M Doses)
Table 107. Global Hepatitis B Vaccines Sales Market Share by Application (2018-2023)
Table 108. Global Hepatitis B Vaccines Sales Market Share by Application (2024-2029)
Table 109. Global Hepatitis B Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Hepatitis B Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Hepatitis B Vaccines Revenue Market Share by Application (2018-2023)
Table 112. Global Hepatitis B Vaccines Revenue Market Share by Application (2024-2029)
Table 113. Global Hepatitis B Vaccines Price by Application (2018-2023) & (USD/Doses)
Table 114. Global Hepatitis B Vaccines Price by Application (2024-2029) & (USD/Doses)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Hepatitis B Vaccines Distributors List
Table 118. Hepatitis B Vaccines Customers List
Table 119. Hepatitis B Vaccines Industry Trends
Table 120. Hepatitis B Vaccines Industry Drivers
Table 121. Hepatitis B Vaccines Industry Restraints
Table 122. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hepatitis B VaccinesProduct Picture
Figure 5. Global Hepatitis B Vaccines Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Hepatitis B Vaccines Market Size (2018-2029) & (US$ Million)
Figure 7. Global Hepatitis B Vaccines Sales (2018-2029) & (M Doses)
Figure 8. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2018-2029)
Figure 9. Yeast Derived Product Picture
Figure 10. CHO Derived Product Picture
Figure 11. Children Product Picture
Figure 12. Adult Product Picture
Figure 13. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Hepatitis B Vaccines Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Hepatitis B Vaccines Sales by Region in 2022
Figure 20. Global Hepatitis B Vaccines Revenue by Region in 2022
Figure 21. North America Hepatitis B Vaccines Market Size by Country in 2022
Figure 22. North America Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 23. North America Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 24. United States Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Hepatitis B Vaccines Market Size by Country in 2022
Figure 27. Europe Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 28. Europe Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 29. Germany Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Hepatitis B Vaccines Market Size by Country in 2022
Figure 35. Asia Pacific Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 37. China Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Hepatitis B Vaccines Market Size by Country in 2022
Figure 47. Latin America Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Hepatitis B Vaccines Market Size by Country in 2022
Figure 53. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Hepatitis B Vaccines Sales Market Share by Type (2018-2029)
Figure 59. Global Hepatitis B Vaccines Revenue Market Share by Type (2018-2029)
Figure 60. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2018-2029)
Figure 61. Global Hepatitis B Vaccines Sales Market Share by Application (2018-2029)
Figure 62. Global Hepatitis B Vaccines Revenue Market Share by Application (2018-2029)
Figure 63. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2018-2029)
Figure 64. Hepatitis B Vaccines Value Chain
Figure 65. Hepatitis B Vaccines Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Hepatitis B Vaccines Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hepatitis B VaccinesProduct Picture
Figure 5. Global Hepatitis B Vaccines Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Hepatitis B Vaccines Market Size (2018-2029) & (US$ Million)
Figure 7. Global Hepatitis B Vaccines Sales (2018-2029) & (M Doses)
Figure 8. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2018-2029)
Figure 9. Yeast Derived Product Picture
Figure 10. CHO Derived Product Picture
Figure 11. Children Product Picture
Figure 12. Adult Product Picture
Figure 13. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Hepatitis B Vaccines Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Hepatitis B Vaccines Sales by Region in 2022
Figure 20. Global Hepatitis B Vaccines Revenue by Region in 2022
Figure 21. North America Hepatitis B Vaccines Market Size by Country in 2022
Figure 22. North America Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 23. North America Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 24. United States Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Hepatitis B Vaccines Market Size by Country in 2022
Figure 27. Europe Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 28. Europe Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 29. Germany Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Hepatitis B Vaccines Market Size by Country in 2022
Figure 35. Asia Pacific Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 37. China Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Hepatitis B Vaccines Market Size by Country in 2022
Figure 47. Latin America Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Hepatitis B Vaccines Market Size by Country in 2022
Figure 53. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Hepatitis B Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Hepatitis B Vaccines Sales Market Share by Type (2018-2029)
Figure 59. Global Hepatitis B Vaccines Revenue Market Share by Type (2018-2029)
Figure 60. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2018-2029)
Figure 61. Global Hepatitis B Vaccines Sales Market Share by Application (2018-2029)
Figure 62. Global Hepatitis B Vaccines Revenue Market Share by Application (2018-2029)
Figure 63. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2018-2029)
Figure 64. Hepatitis B Vaccines Value Chain
Figure 65. Hepatitis B Vaccines Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Hepatitis B Vaccines Industry Opportunities and Challenges
